These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18559999)

  • 1. Antihormone therapy in recurrent metastatic breast cancer.
    Pritchard KI
    JAMA; 2008 Jun; 299(23):2745; author reply 2745. PubMed ID: 18559999
    [No Abstract]   [Full Text] [Related]  

  • 2. [AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer].
    Longo F; Mansueto G
    Tumori; 2004; 90(6):1-12. PubMed ID: 15762372
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer (metastatic).
    Stebbing J; Crane J; Gaya A
    Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of aromatase inhibitor (AI) in the treatment of breast cancer.
    Irawan C; Abdulmuthalib
    Acta Med Indones; 2005; 37(1):43-8. PubMed ID: 15879638
    [No Abstract]   [Full Text] [Related]  

  • 5. Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.
    Pritchard KI
    J Clin Oncol; 2005 Aug; 23(22):4850-2. PubMed ID: 16009956
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progestational agents and bone metastasis in breast cancer].
    Leriche N; Bonneterre J
    Bull Cancer; 1997 Sep; 84(9):891-4. PubMed ID: 9435812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. By the way, doctor. Should I switch from tamoxifen to an aromatase inhibitor?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Jun; 14(10):8. PubMed ID: 18018318
    [No Abstract]   [Full Text] [Related]  

  • 8. [Utility of neoadjuvant endocrine therapy for breast neoplasms].
    Akashi-Tanaka S
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():559-62. PubMed ID: 17682211
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer (metastatic).
    Stebbing J; Glassman R
    Clin Evid; 2004 Jun; (11):2266-99. PubMed ID: 15652111
    [No Abstract]   [Full Text] [Related]  

  • 10. Tamoxifen in breast cancer: not so easy to write off.
    Munshi A; Singh P
    Breast; 2008 Apr; 17(2):121-4. PubMed ID: 17923407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic breast cancer: overview of treatment.
    Ali SM; Harvey HA; Lipton A
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S132-7. PubMed ID: 14600603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
    Winer E
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
    [No Abstract]   [Full Text] [Related]  

  • 13. Aromatase inhibitors in breast cancer: an overview.
    Altundag K; Ibrahim NK
    Oncologist; 2006 Jun; 11(6):553-62. PubMed ID: 16794235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the quality of life of women with breast cancer in adjuvant treatment with tamoxifen or aromatase inhibitors--a randomized trial].
    Volovăţ C; Volovăţ SR; Dogaru C; Vulpoi C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):53-7. PubMed ID: 21688560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors--extending the benefits of adjuvant therapy beyond tamoxifen.
    Smith IE
    Breast; 2004 Dec; 13 Suppl 1():S3-9. PubMed ID: 15585377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.
    Singh Ranger G
    J Clin Pharm Ther; 2005 Aug; 30(4):313-7. PubMed ID: 15985044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal therapy in breast cancer].
    Espinós J; Reyna C; de la Cruz S; Oiler C; Hernández A; Fernández Hidalgo O; Santisteban M; García Foncillas J
    Rev Med Univ Navarra; 2008; 52(1):40-8. PubMed ID: 18578196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.
    Ryan PD; Goss PE
    Nat Clin Pract Oncol; 2005 Dec; 2(12):596-7. PubMed ID: 16341095
    [No Abstract]   [Full Text] [Related]  

  • 19. Which is the appropriate adjuvant endocrine therapy for premenopausal patients with breast cancer?
    Petrelli F; Barni S
    Clin Breast Cancer; 2015 Jun; 15(3):169-70. PubMed ID: 25600162
    [No Abstract]   [Full Text] [Related]  

  • 20. Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
    Van Poznak CH; Hayes DF
    J Natl Cancer Inst; 2006 Sep; 98(18):1261-3. PubMed ID: 16985239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.